The report on global therapeutic vaccines market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global therapeutic vaccines market to grow with a CAGR of 7.3% over the forecast period of 2018-2024. The study on therapeutic vaccines market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The major driving factor such as increasing occurrence of cancer, cardiovascular diseases, HIV infection and various chronic diseases are boosting the therapeutic vaccines market. In addition, Increase in funding’s from government for vaccine development and growing awareness among people for severe disease are the key factors escalating the growth of Therapeutic Vaccines Market. However, high cost associated with treatment is expected to hinder the growth of Therapeutic Vaccines Market. Moreover, various pharmaceutical players in this market are extensively researching on the research & Development activities to develop novel vaccines for several diseases that may create growth opportunities for Therapeutic Vaccines Market in the near future.
Among the geographies, North America is the leading contributor in the Therapeutic Vaccines Market. The U.S has the largest market share in the North America region. Developed medical and healthcare infrastructure and increasing funding for research and development activities are the few factors augmenting the growth in the North America region. On the other hand, Asia Pacific region is anticipated to be the fastest growing market in upcoming year owing to the increasing prevalence of various diseases, rising disposable income and rapidly growing aging population.
The report on therapeutic vaccines market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global therapeutic vaccines market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global therapeutic vaccines market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies
The global therapeutic vaccines market is segmented on the basis of vaccines type, disease indication, administration and end user.
Global Therapeutic Vaccines Market by Vaccines Type
? Auto Immune Diseases Vaccines
? Neurological Disease Vaccines
? Chronic Disease Vaccines
? Infectious Diseases Vaccines
Global Therapeutic Vaccines Market by Disease Indication
? Pneumococcal Disease
? Human Papilloma Virus
? Meningococcal Disease
Global Therapeutic Vaccines Market by Administration
? Intramuscular And Subcutaneous Administration
? Oral Administration
? Other Routes Of Administration
Global Therapeutic Vaccines Market by End User
? Pfizer, Inc.
? Glaxosmithkline PLC.
? Merck & Co., Inc.
? Sanofi Pasteur SA
? CSL Limited
? Emergent Biosolutions, Inc.
? Johnson & Johnson
? Astellas Pharma, Inc.
? Serum Institute of India
How this report delivers?
1. Comprehensive analysis of global as well as regional markets of therapeutic vaccines market.
2. Complete coverage of all the segments in therapeutic vaccines market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global therapeutic vaccines market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.